Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$78
|
$221B |
3.4x |
8.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$175B |
2.8x |
7.2x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€93
|
$144B |
2.8x |
9.6x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$96.5B |
2.3x |
6.6x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 246
|
$87.2B |
5.6x |
16.8x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€160
|
$36.0B |
4.9x |
18.7x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 68
|
$11.5B |
N/A |
N/A |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$99
|
$8.2B |
3.0x |
-6.0x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$8.2B |
2.3x |
19.0x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 174
|
$5.9B |
6.7x |
24.6x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3019
|
$5.7B |
12.8x |
40.9x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$5.1B |
1.8x |
-1.3x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.7B |
5.8x |
14.3x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.8B |
60.5x |
N/A |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 40
|
$2.8B |
7.6x |
46.7x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$34
|
$2.8B |
N/A |
N/A |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 14
|
$2.4B |
6.1x |
22.1x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8002
|
$2.3B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 10
|
$1.8B |
4.6x |
22.1x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 169
|
$1.8B |
2.0x |
6.9x |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 42850
|
$1.8B |
6.3x |
-47.1x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 43
|
$1.6B |
11.7x |
-19.3x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 14021
|
$1.2B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 21
|
$1.2B |
6.7x |
23.3x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€28
|
$1.2B |
N/A |
N/A |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$1.1B |
5.8x |
8.0x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 7
|
$958M |
5.3x |
20.5x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$922M |
6.5x |
13.0x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 54
|
$882M |
4.3x |
11.2x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 9
|
$829M |
11.7x |
13.0x |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 4
|
$823M |
4.4x |
N/A |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$804M |
2.7x |
20.9x |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$740M |
3.1x |
10.0x |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$20
|
$683M |
120.4x |
-3.2x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$7
|
$678M |
0.9x |
18.7x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€3
|
$602M |
3.0x |
79.9x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 4
|
$601M |
11.0x |
-29.2x |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 9
|
$599M |
N/A |
-10.0x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 485
|
$597M |
N/A |
N/A |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$573M |
N/A |
N/A |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 51
|
$511M |
24.0x |
165.5x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$488M |
6.3x |
-19.4x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$4
|
$480M |
1.2x |
5.0x |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$476M |
N/A |
N/A |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 21
|
$471M |
438.1x |
-23.2x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$424M |
59.1x |
-1.6x |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 384
|
$415M |
N/A |
N/A |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$362M |
83.4x |
-20.1x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 24
|
$327M |
1.9x |
8.6x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$21
|
$285M |
3.4x |
-2.6x |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 19
|
$280M |
N/A |
N/A |
Coherus BioSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$277M |
1.5x |
-2.7x |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 24
|
$267M |
1.4x |
6.6x |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$264M |
2.1x |
14.9x |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$261M |
75.5x |
N/A |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$238M |
N/A |
N/A |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$225M |
739.5x |
N/A |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$214M |
24.5x |
-0.7x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 41
|
$213M |
N/A |
N/A |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$190M |
N/A |
-5.4x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$184M |
347.1x |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$177M |
1.7x |
N/A |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$168M |
216.4x |
N/A |
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$155M |
6682.8x |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 18
|
$151M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$148M |
25.0x |
-9.3x |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€6
|
$146M |
1.9x |
4.0x |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$144M |
N/A |
N/A |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 23
|
$138M |
N/A |
N/A |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9200
|
$129M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$128M |
N/A |
N/A |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$127M |
N/A |
N/A |
Vaxart
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$82.2M |
3.1x |
N/A |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$71.1M |
34.3x |
-0.7x |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$71.0M |
2.8x |
N/A |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$69.8M |
N/A |
N/A |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$69.6M |
43.3x |
-0.8x |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$69.2M |
0.7x |
-2.0x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$66.7M |
N/A |
N/A |
LakeShore Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$65.9M |
N/A |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$65.4M |
2.9x |
-2.8x |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$61.9M |
0.5x |
-0.8x |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$60.6M |
12463.7x |
-2.6x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$60.0M |
13.5x |
N/A |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$56.8M |
N/A |
N/A |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$52.3M |
N/A |
-2.4x |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$50.7M |
N/A |
-1.3x |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$47.3M |
6.1x |
N/A |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$44.0M |
0.5x |
-0.4x |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$43.7M |
N/A |
-0.5x |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$40.5M |
N/A |
N/A |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$40.2M |
N/A |
N/A |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$39.7M |
2132.0x |
-0.2x |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$39.1M |
0.3x |
-0.5x |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$30.2M |
N/A |
N/A |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$29.1M |
1.3x |
N/A |
HCW Biologics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$26.1M |
27.2x |
N/A |
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$17.0M |
98.6x |
N/A |
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$14.3M |
N/A |
N/A |
Geovax Labs
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$1
|
$14.1M |
4.8x |
N/A |